Welcome to Columbia Business School's Healthcare and Pharmaceutical Management Program! We invite you to join our community of dedicated students, alumni, and faculty as we pioneer the future of healthcare. Our program, enriched by the vibrant city life of New York and inspired by the cutting-edge research and industry insights of our faculty, promises a transformative journey.
Professor Chan teaches the MBA core Operations Management course and the MBA electives, The US Healthcare System: Structures and Strategies; Healthcare Management, Design, and Strategy; and The Analytics Advantage. Her research is in the area of healthcare operations management. Her primary focus is in data-driven modeling of healthcare systems. Her research combines empirical and mathematical modeling to develop evidence-based approaches to improve patient flow.
Professor Cramer spent more than 25 years in the healthcare, pharmaceutical, and financial services sectors. He was Managing Director at Merrill Lynch in the Global Healthcare Investment Banking Group, and Managing Director at JPMorgan in the Corporate Finance Group providing M&A services and financing to global healthcare enterprises. Earlier, Prof. Cramer was Vice President, Corporate Planning & Development for Merck & Co., Inc. with worldwide responsibilities for strategic planning and business development.
Shannon Ingraham is the Administrative Director in the Healthcare and Pharmaceutical Management program. Prior to joining Columbia Business School, Shannon was the Department Administrator for Harvard University Faculty of Arts and Sciences Finance Department and was responsible for departmental operations.
Samantha Jean-Baptiste is the Program Manager for the Healthcare and Pharmaceutical Management Program (HPM) at Columbia Business School. In this role, she is responsible for the administrative coordination and management of HPM.
Efrem Kamen is Managing Member at Pura Vida Investments, a life sciences investment firm he co-founded in 2012. The firm has significant investments across the healthcare universe, including Medical Technology, Life Science Tools and Biotechnology.
Frank R. Lichtenberg is Cain Brothers & Company Professor of Healthcare Management in the Faculty of Business Economics at the Columbia University Graduate School of Business; a Research Associate of the National Bureau of Economic Research; and a member of the CESifo Research Network. He received a BA with Honors in History from the University of Chicago and an MA and PhD in Economics from the University of Pennsylvania.